Skip to content

OSR HEALTH, INC.: 10-Q filed 2025-11-12

What OSR HEALTH, INC. reported in its quarterly report filed 2025-11-12 (fiscal Q3 2025): 47 published measures, 127 facts as tagged in accession 0001213900-25-109054.

This filing

Form
10-Q (quarterly report)
Filed
2025-11-12
Fiscal period
fiscal Q3 2025
Accession
0001213900-25-109054 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All OSR HEALTH, INC. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2025-09-30177,289,528USD
At 2024-12-31175,239,579USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

PeriodValueUnitDays
At 2025-09-3043,131,683USD
At 2024-12-3132,031,364USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

PeriodValueUnitDays
At 2025-09-302,177,309USD
At 2024-12-31341,543USD

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

PeriodValueUnitDays
2025-01-01 to 2025-09-30-3,258,041USD273
2024-01-01 to 2024-09-30-1,668,444USD274

Revenue

Revenue under this specific accounting concept. A missing value is not zero; filers can use other revenue concepts.

PeriodValueUnitDays
2025-07-01 to 2025-09-30627,747USD92
2025-01-01 to 2025-09-302,524,536USD273
2024-07-01 to 2024-09-30822,996USD92
2024-01-01 to 2024-09-302,615,051USD274

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

PeriodValueUnitDays
2025-01-01 to 2025-09-305,156,580USD273
2024-01-01 to 2024-09-30862,818USD274

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

PeriodValueUnitDays
2025-01-01 to 2025-09-30-69,465USD273
2024-01-01 to 2024-09-30691,423USD274

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

PeriodValueUnitDays
At 2025-09-30-32,327,645USD
At 2024-12-31-19,173,063USD

Basic weighted-average shares

Time-weighted shares used for basic earnings per share. This denominator differs from shares outstanding at a single reporting date.

PeriodValueUnitDays
2025-01-01 to 2025-09-3017,375,710shares273
2024-01-01 to 2024-09-302,155,000shares274

Diluted weighted-average shares

Weighted-average shares used for diluted earnings per share. Potential shares are included under the applicable dilution rules, not simply added to outstanding shares.

PeriodValueUnitDays
2025-01-01 to 2025-09-3023,118,372shares273
2024-01-01 to 2024-09-302,155,000shares274

Basic earnings per share

Reported earnings or loss per basic common share or unit. Inspect attribution, share classes and restatements before comparing periods. This is not a market return.

PeriodValueUnitDays
2025-07-01 to 2025-09-30-0.1USD/shares92
2025-01-01 to 2025-09-30-0.76USD/shares273
2024-07-01 to 2024-09-30-1.56USD/shares92
2024-01-01 to 2024-09-30-4.17USD/shares274

Diluted earnings per share

Reported earnings or loss per share under dilution rules. Antidilutive instruments may be excluded. A diluted value can equal the basic value without implying no potential dilution.

PeriodValueUnitDays
2025-01-01 to 2025-09-30-0.57USD/shares273
2024-01-01 to 2024-09-30-4.17USD/shares274

Income tax expense or benefit

Current and deferred income tax expense or benefit for continuing operations. This accounting expense differs from cash taxes paid.

PeriodValueUnitDays
2025-07-01 to 2025-09-30-1,294,952USD92
2025-01-01 to 2025-09-30-1,294,952USD273
2024-07-01 to 2024-09-30-139,560USD92
2024-01-01 to 2024-09-30-1,113,183USD274

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

PeriodValueUnitDays
At 2025-09-3098,109USD
At 2024-12-312,334USD

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

PeriodValueUnitDays
2025-07-01 to 2025-09-30-3,803,465USD92
2025-01-01 to 2025-09-30-11,950,469USD273
2024-07-01 to 2024-09-30-3,566,542USD92
2024-01-01 to 2024-09-30-10,079,178USD274

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2025-09-303,204,215USD
At 2024-12-312,326,489USD

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

PeriodValueUnitDays
At 2025-09-3015,032,007USD
At 2024-12-313,463,212USD

Goodwill carrying amount

Recognized goodwill remaining after accumulated impairment. It arises from business combinations and does not measure the current value of the company’s brand.

PeriodValueUnitDays
At 2025-09-3025,531,648USD
At 2024-12-3124,354,066USD
At 2024-09-3026,581,881USD
At 2023-12-3127,765,222USD

Net finite-lived intangible assets

Finite-lived intangible assets after amortization. This excludes goodwill and should not be combined with indefinite-lived intangible assets without checking scope.

PeriodValueUnitDays
At 2025-09-30148,152,920USD
At 2024-12-31148,056,852USD

Net current accounts receivable

Current customer receivables after the allowance for credit loss. The balance is not cash collected or a guarantee of collection.

PeriodValueUnitDays
At 2025-09-30489,181USD
At 2024-12-31904,456USD

Net inventory

Inventory carrying amount after applicable valuation and LIFO reserves. It does not establish realizable selling proceeds or inventory turnover without other inputs.

PeriodValueUnitDays
At 2025-09-30185,095USD
At 2024-12-31922,107USD

Gross profit

Revenue less the costs directly attributed to the goods or services sold. It precedes other operating expenses and is not net income.

PeriodValueUnitDays
2025-07-01 to 2025-09-30261,734USD92
2025-01-01 to 2025-09-30463,201USD273
2024-07-01 to 2024-09-30179,093USD92
2024-01-01 to 2024-09-30651,215USD274

Cost of revenue

Costs attributed to goods produced and sold and services provided during the period. This is not the sum of every operating expense.

PeriodValueUnitDays
2025-07-01 to 2025-09-30366,014USD92
2025-01-01 to 2025-09-302,061,335USD273
2024-07-01 to 2024-09-30643,903USD92
2024-01-01 to 2024-09-301,963,835USD274

Selling, general and administrative expense

Selling and general administrative costs reported under this concept. It is an expense category, not a substitute for total operating expenses.

PeriodValueUnitDays
2025-07-01 to 2025-09-304,065,199USD92
2025-01-01 to 2025-09-3012,413,670USD273
2024-07-01 to 2024-09-303,745,635USD92
2024-01-01 to 2024-09-3010,730,393USD274

Research and development expense

Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.

PeriodValueUnitDays
2025-01-01 to 2025-09-30141,880USD273
2024-01-01 to 2024-09-30146,679USD274

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

PeriodValueUnitDays
At 2025-09-3023,671,217shares
At 2024-12-312,155,000shares

Cash including restricted cash

Cash, cash equivalents and restricted cash as reported in the cash flow reconciliation. Restricted amounts are not freely available, so this is not the same as unrestricted cash.

PeriodValueUnitDays
At 2025-09-302,177,309USD
At 2024-12-31341,543USD
At 2024-09-30522,997USD
At 2023-12-31540,207USD

Accumulated other comprehensive income or loss

Cumulative other comprehensive items after tax, such as translation and unrealized hedging or securities effects. These amounts have not passed through net income.

PeriodValueUnitDays
At 2025-09-304,721,717USD
At 2024-12-31-225,386USD

Total equity including noncontrolling interests

Equity including the portion attributable to noncontrolling interests. It is larger than or equal to parent stockholders equity and is not market capitalization.

PeriodValueUnitDays
At 2025-09-30134,157,845USD
At 2025-06-30139,151,113USD
At 2024-12-31143,208,215USD
At 2024-09-3087,565,364USD
At 2024-06-3090,921,794USD
At 2023-12-3196,531,073USD

Operating lease right-of-use asset

Carrying amount of the right to use leased assets under operating leases. It reflects discounted remaining payments, not the value of the underlying property.

PeriodValueUnitDays
At 2025-09-3050,371USD
At 2024-12-3178,484USD

Gross property, plant and equipment

Cost of property, plant and equipment before accumulated depreciation. Historical cost does not indicate current value or replacement cost.

PeriodValueUnitDays
At 2025-09-30389,661USD
At 2024-12-31291,838USD

Accumulated depreciation on property, plant and equipment

Cumulative depreciation, depletion and amortization recorded against property, plant and equipment. It measures cost allocation to date, not physical wear or market value.

PeriodValueUnitDays
At 2025-09-30291,552USD
At 2024-12-31289,504USD

Net intangible assets excluding goodwill

Intangible assets other than goodwill after amortization and impairment. Internally developed intangibles are usually not recognized, so this understates what a company relies on.

PeriodValueUnitDays
At 2025-09-30148,152,920USD
At 2024-12-31148,056,852USD

Other noncurrent liabilities

Noncurrent liabilities the filer does not present separately. The composition differs by filer and is described only in the filing.

PeriodValueUnitDays
At 2025-09-301,737USD
At 2024-12-311,657USD

Accrued current liabilities

Current obligations accrued for goods and services received but not yet invoiced or paid. This is one component of current liabilities, not all short-term obligations.

PeriodValueUnitDays
At 2025-09-30977,446USD
At 2024-12-31459,883USD

Net deferred tax liabilities

Deferred tax liabilities net of related assets under this concept. The amount reflects timing differences and is not tax currently due.

PeriodValueUnitDays
At 2025-09-3028,086,365USD
At 2024-12-3128,035,508USD

Pre-tax income or loss from continuing operations

Income or loss from continuing operations before income taxes and noncontrolling interests. It excludes discontinued operations and is not net income.

PeriodValueUnitDays
2025-07-01 to 2025-09-30-4,489,826USD92
2025-01-01 to 2025-09-30-21,107,838USD273
2024-07-01 to 2024-09-30-3,496,094USD92
2024-01-01 to 2024-09-30-10,102,570USD274

Profit or loss including noncontrolling interests

Net income or loss including the portion attributable to noncontrolling interests. It can differ from the net income attributable to the parent that per-share figures use.

PeriodValueUnitDays
2025-07-01 to 2025-09-30-3,194,874USD92
2025-01-01 to 2025-09-30-19,812,886USD273
2025-01-01 to 2025-06-30-16,618,012USD181
2024-07-01 to 2024-09-30-3,356,533USD92
2024-01-01 to 2024-09-30-8,989,387USD274
2024-01-01 to 2024-06-30-5,632,853USD182

Comprehensive income or loss

Net income plus other comprehensive income after tax. It includes unrealized items that net income excludes and is not a cash measure.

PeriodValueUnitDays
2025-07-01 to 2025-09-30-3,629,440USD92
2025-01-01 to 2025-09-30-9,895,069USD273
2024-07-01 to 2024-09-30-3,356,430USD92
2024-01-01 to 2024-09-30-8,965,709USD274

Net income available to common stockholders

Net income after preferred dividends and similar adjustments, the numerator for basic earnings per share. It can be lower than reported net income.

PeriodValueUnitDays
2025-07-01 to 2025-09-30-2,126,595USD92
2025-01-01 to 2025-09-30-13,187,995USD273
2024-07-01 to 2024-09-30-3,356,533USD92
2024-01-01 to 2024-09-30-8,989,387USD274

Depreciation expense

Depreciation recognized for the period under this concept. It is a noncash allocation of asset cost and may exclude amortization and depletion reported elsewhere.

PeriodValueUnitDays
2025-01-01 to 2025-09-30894USD273
2024-01-01 to 2024-09-3047,849USD274

Amortization of intangible assets

Amortization recognized on finite-lived intangible assets. It follows acquisition accounting and does not indicate the intangibles are losing usefulness at that rate.

PeriodValueUnitDays
2025-01-01 to 2025-09-307,010,647USD273
2024-01-01 to 2024-09-308,488,493USD274

Nonoperating interest expense

Interest expense presented outside operating results. It differs from total interest expense when some borrowing cost is classified as operating or capitalized.

PeriodValueUnitDays
2025-07-01 to 2025-09-3043,866USD92
2025-01-01 to 2025-09-3097,194USD273
2024-07-01 to 2024-09-309,114USD92
2024-01-01 to 2024-09-3024,729USD274

Interest paid, net

Cash interest paid during the period, net of amounts capitalized where the filer reports it that way. It differs from interest expense recognized.

PeriodValueUnitDays
2025-01-01 to 2025-09-3097,803USD273
2024-01-01 to 2024-09-3037,311USD274

Income taxes paid, net

Cash income taxes paid net of refunds during the period. It differs from income tax expense and can reflect prior years and estimated payments.

PeriodValueUnitDays
2025-01-01 to 2025-09-30-26,525USD273
2024-01-01 to 2024-09-3013,765USD274

Proceeds from issuing common stock

Cash received from issuing common stock during the period. It is gross of costs only where the filer reports it so, and it does not include noncash issuances.

PeriodValueUnitDays
2025-01-01 to 2025-09-303,385,038USD273

Change in inventories

The cash flow adjustment for the change in inventories during the period. A positive value under this concept means inventory grew and reduced operating cash flow.

PeriodValueUnitDays
2025-01-01 to 2025-09-30-784,631USD273
2024-01-01 to 2024-09-30-271,945USD274

Inspect the source

Entity
OSR HEALTH, INC. / CIK 0001840425
Captured
2026-09-21T17:37:27.107Z
SEC response SHA-256
a0d30433e6a20a35440697935a5f38c30b52570c7afa4a92b7b1c23550f84d90

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001840425.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))